Figure 2: MRI before and after chemotherapy. (A) T1-weighted gadoliniumenhanced magnetic resonance imaging (MRI) from May 2005 demonstrated a well-enhanced mass in bilateral temporal lesion. (B) T1-weighted gadoliniumenhanced MRI from April 2006. No evident tumor after nimustine hydrochloride.